CAI Q4 2020 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M-35.8% YoY

Gross Profit

$41M63.4% margin

Operating Income

$36M56.1% margin

Net Income

$14M22.1% margin

EPS (Diluted)

$0.79

QoQ Revenue Growth

-18.6%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

-$91M

Stock-Based Comp.

$359,000

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.9B

Stockholders' Equity

$702M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$100M	-35.8%
Gross Profit	$41M	$48M	-14.3%
Operating Income	$36M	$28M	+28.3%
Net Income	$14M	$8M	+81.5%